Literature DB >> 24418574

FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.

Chen Huang1, Jiawei Du2, Keping Xie3.   

Abstract

Pancreatic cancer is a devastating disease with an overall 5-year survival rate less than 5%. Multiple signaling pathways are implicated in the pathogenesis of pancreatic cancer, such as Wnt/β-catenin, Notch, Hedgehog, hypoxia-inducible factor, signal transducer and activator of transcription, specificity proteins/Krüppel-like factors, and Forkhead box (FOX). Recently, increasing evidence has demonstrated that the transcription factor FOXM1 plays important roles in the initiation, progression, and metastasis of a variety of human tumors, including pancreatic cancer. In this review, we focus on the current understanding of the molecular pathogenesis of pancreatic cancer with a special focus on the function and regulation of FOXM1 and rationale for FOXM1 as a novel molecular target for pancreatic cancer prevention and treatment.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FOXM1; Metastasis; Pancreatic cancer; Progression; Transcription factor

Mesh:

Substances:

Year:  2014        PMID: 24418574      PMCID: PMC3995850          DOI: 10.1016/j.bbcan.2014.01.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  142 in total

Review 1.  Pancreatic cancer.

Authors:  Theresa Pluth Yeo; Ralph H Hruban; Steven D Leach; Robb E Wilentz; Taylor A Sohn; Scott E Kern; Christine A Iacobuzio-Donahue; Anirban Maitra; Michael Goggins; Marcia I Canto; Ross A Abrams; Daniel Laheru; Elizabeth M Jaffee; Manuel Hidalgo; Charles J Yeo
Journal:  Curr Probl Cancer       Date:  2002 Jul-Aug       Impact factor: 3.187

Review 2.  Cell cycle regulation and neural differentiation.

Authors:  Umberto Galderisi; Francesco Paolo Jori; Antonio Giordano
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

3.  FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.

Authors:  Xiao-Yuan Chu; Zi-Man Zhu; Long-Bang Chen; Jing-Hua Wang; Quan-Sheng Su; Ji-Rong Yang; Yong Lin; Li-Jun Xue; Xiao-Bei Liu; Xiao-Bei Mo
Journal:  Acta Histochem       Date:  2012-02-11       Impact factor: 2.479

Review 4.  Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition.

Authors:  Amparo Cano; M Angela Nieto
Journal:  Trends Cell Biol       Date:  2008-06-26       Impact factor: 20.808

5.  FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.

Authors:  Chen Huang; Dacheng Xie; Jiujie Cui; Qi Li; Yong Gao; Keping Xie
Journal:  Clin Cancer Res       Date:  2014-01-22       Impact factor: 12.531

Review 6.  Adjuvant therapy in pancreatic cancer: historical and current perspectives.

Authors:  J P Neoptolemos; D Cunningham; H Friess; C Bassi; D D Stocken; D M Tait; J A Dunn; C Dervenis; F Lacaine; H Hickey; M G T Raraty; P Ghaneh; M W Büchler
Journal:  Ann Oncol       Date:  2003-05       Impact factor: 32.976

7.  Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors.

Authors:  I-C Wang; L Meliton; M Tretiakova; R H Costa; V V Kalinichenko; T V Kalin
Journal:  Oncogene       Date:  2008-03-17       Impact factor: 9.867

8.  Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.

Authors:  Xiangyu Kong; Lei Li; Zhaoshen Li; Xiangdong Le; Chen Huang; Zhiliang Jia; Jiujie Cui; Suyun Huang; Liwei Wang; Keping Xie
Journal:  Cancer Res       Date:  2013-04-18       Impact factor: 12.701

Review 9.  Transcription factors and cancer: an overview.

Authors:  Daniel W Nebert
Journal:  Toxicology       Date:  2002-12-27       Impact factor: 4.221

10.  The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.

Authors:  Xiaolu Zhang; Jiping Zeng; Minran Zhou; Bingnan Li; Yuanyuan Zhang; Tao Huang; Lixiang Wang; Jihui Jia; Chunyan Chen
Journal:  Mol Cancer       Date:  2012-08-17       Impact factor: 27.401

View more
  27 in total

1.  Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.

Authors:  Ming Quan; Jiujie Cui; Tian Xia; Zhiliang Jia; Dacheng Xie; Daoyan Wei; Suyun Huang; Qian Huang; Shaojiang Zheng; Keping Xie
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

Review 2.  Targeting forkhead box M1 transcription factor in breast cancer.

Authors:  Ruth M O'Regan; Rita Nahta
Journal:  Biochem Pharmacol       Date:  2018-05-31       Impact factor: 5.858

3.  A FOXM1 related long non-coding RNA contributes to gastric cancer cell migration.

Authors:  Hui Cai; Jingde Chen; Bin He; Qiang Li; Yandong Li; Yong Gao
Journal:  Mol Cell Biochem       Date:  2015-04-24       Impact factor: 3.396

4.  Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells.

Authors:  Meng Yue; Shiquan Li; Guoqiang Yan; Chenyao Li; Zhenhua Kang
Journal:  Cell Cycle       Date:  2018-01-05       Impact factor: 4.534

5.  Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.

Authors:  Dragana Kopanja; Akshay Pandey; Megan Kiefer; Zebin Wang; Neha Chandan; Janai R Carr; Roberta Franks; Dae-Yeul Yu; Grace Guzman; Ajay Maker; Pradip Raychaudhuri
Journal:  J Hepatol       Date:  2015-03-28       Impact factor: 25.083

6.  Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells.

Authors:  Xinping Yang; Yuanyuan Shi; Jingzhe Yan; Haitao Fan
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

7.  Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance.

Authors:  Xiaoxiao Li; Kai Ma; Shanai Song; Fangzhen Shen; Tao Kuang; Yingqian Zhu; Zimin Liu
Journal:  Clin Exp Med       Date:  2018-05-26       Impact factor: 3.984

8.  UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.

Authors:  Zhiwang Song; Junhe Li; Ling Zhang; Jun Deng; Ziling Fang; Xiaojun Xiang; Jianping Xiong
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

9.  NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS.

Authors:  Mitali Chattopadhyay; Ravinder Kodela; Gabriela Santiago; Thuy Tien C Le; Niharika Nath; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-02-14       Impact factor: 5.858

10.  Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis.

Authors:  Hong Chen; Jingjing Wang; Hong Yang; Dan Chen; Panpan Li
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.